All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

A conceptual deep learning framework for COVID-19 drug discovery

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F49777513%3A23220%2F21%3A43963863" target="_blank" >RIV/49777513:23220/21:43963863 - isvavai.cz</a>

  • Result on the web

    <a href="https://ieeexplore.ieee.org/document/9666715" target="_blank" >https://ieeexplore.ieee.org/document/9666715</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1109/UEMCON53757.2021.9666715" target="_blank" >10.1109/UEMCON53757.2021.9666715</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    A conceptual deep learning framework for COVID-19 drug discovery

  • Original language description

    The analytical and experimental methods used for the development of drugs have some disadvantages in the aspect of the needed time for preparation of the desired parenthetical products and the efficiency of them, which not only can the risk for failure increase, particularly when pathogens are impossible to be cultivated under laboratory conditions, but these approaches can also lead to achieving arrays of antigens that are not able to provide sufficient immunity to combat the targeted disease. On the other hand, artificial intelligence (AI) and its new branches, including deep learning (DL) and machine learning (ML) techniques can be deployed for drug development purposes in order to alleviate the difficulties associated with conventional methods. Moreover, intelligent methods will provide researchers with the opportunity to use some userfriendly and efficient services to conquer such problems. In this respect, a conceptual DL framework has been studied in order to demonstrate the capability and applicability of these methods. Accordingly, a framework has been proposed to show how COVID-19 drug development can benefit from the potentials of AI and DL.

  • Czech name

  • Czech description

Classification

  • Type

    D - Article in proceedings

  • CEP classification

  • OECD FORD branch

    20206 - Computer hardware and architecture

Result continuities

  • Project

    <a href="/en/project/EF18_069%2F0009855" target="_blank" >EF18_069/0009855: Electrical Engineering Technologies with High-Level of Embedded Intelligence</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Article name in the collection

    Proceedings of 2021 IEEE 12th Annual Ubiquitous Computing, Electronics &amp; Mobile Communication Conference (IEEE UEMCON)

  • ISBN

    978-1-66540-690-1

  • ISSN

  • e-ISSN

  • Number of pages

    5

  • Pages from-to

    0030-0034

  • Publisher name

    IEEE

  • Place of publication

    Piscaway

  • Event location

    virtual, New York, USA

  • Event date

    Dec 1, 2021

  • Type of event by nationality

    WRD - Celosvětová akce

  • UT code for WoS article